Sign Up
OverviewAPI
CEOs of Merck and Johnson & Johnson have agreed to testify at a Senate hearing on high drug prices in the U.S., following initial declines. The hearing aims to address the disparity between drug prices in the U.S. and other countries, with a focus on making costly medications more affordable for seniors through Medicare drug price negotiations.

Ask a question